We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$42.1M
Cap. Flow
+$6.1M
Cap. Flow %
1.59%
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$3.64M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.27M
3
GILD icon
Gilead Sciences
GILD
+$1.9M
4
SBCF icon
Seacoast Banking Corp of Florida
SBCF
+$1.75M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.53M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$1.7M
2
NVDA icon
NVIDIA
NVDA
+$477K
3
ET icon
Energy Transfer Partners
ET
+$408K
4
IBM icon
IBM
IBM
+$398K
5
MCD icon
McDonald's
MCD
+$344K

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 14.79%
3 Consumer Staples 13.71%
4 Miscellaneous 12.81%
5 Financials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VGK icon
276
Vanguard FTSE Europe ETF
VGK
$30.9B
$12K ﹤0.01%
200
– –
MPT
277
Medical Properties Trust
MPT
$2.44B
$11K ﹤0.01%
500
– –
BMY.RT
278
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$11K ﹤0.01%
15,915
– –
EEM icon
279
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$10K ﹤0.01%
200
– –
MJ icon
280
Amplify Alternative Harvest ETF
MJ
$117M
$10K ﹤0.01%
60
– –
FRC
281
DELISTED
First Republic Bank
FRC
$10K ﹤0.01%
65
– –
AMBA icon
282
Ambarella
AMBA
$3.1B
$9K ﹤0.01%
100
– –
CRM icon
283
Salesforce
CRM
$211B
$9K ﹤0.01%
40
-28
-41% -$6.81K
GSK icon
284
GSK
GSK
$102B
$9K ﹤0.01%
200
– –
IRM icon
285
Iron Mountain
IRM
$35B
$9K ﹤0.01%
308
– –
MA icon
286
Mastercard
MA
$521B
$9K ﹤0.01%
26
– –
BGS icon
287
B&G Foods
BGS
$286M
$8K ﹤0.01%
300
– –
CLH icon
288
Clean Harbors
CLH
$16.4B
$8K ﹤0.01%
100
– –
FSLR icon
289
First Solar
FSLR
$22B
$8K ﹤0.01%
80
– –
PRFZ icon
290
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.83B
$8K ﹤0.01%
250
– –
RIO icon
291
Rio Tinto
RIO
$168B
$8K ﹤0.01%
100
– –
URI icon
292
United Rentals
URI
$64.1B
$8K ﹤0.01%
35
– –
SPLK
293
DELISTED
Splunk Inc
SPLK
$8K ﹤0.01%
47
– –
AOUT icon
294
American Outdoor Brands
AOUT
$131M
$7K ﹤0.01%
400
– –
C icon
295
Citigroup
C
$223B
$7K ﹤0.01%
115
– –
ELV icon
296
Elevance Health
ELV
$85.5B
$7K ﹤0.01%
21
– –
RGR icon
297
Sturm, Ruger & Co
RGR
$595M
$7K ﹤0.01%
100
– –
SLV icon
298
iShares Silver Trust
SLV
$32.3B
$7K ﹤0.01%
300
– –
VOD icon
299
Vodafone
VOD
$37.1B
$7K ﹤0.01%
452
+131
+41% +$2.05K
AAL icon
300
American Airlines Group
AAL
$9.03B
$6K ﹤0.01%
+400
New +$5.54K
10 11
12
13 14

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
  • American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
  • American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
  • American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
  • American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
  • American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
  • American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.

Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.